Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy

Author： Kesavan Murali   Boucek Jan   MacDonald William   McQuillan Andrew   Turner J. Harvey  

Publisher： MDPI

E-ISSN： 2075-4418|7|2|26-26

ISSN： 2075-4418

Source： Diagnostics, Vol.7, Iss.2, 2017-05, pp. : 26-26

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy

By Grover Natalie S.   Park Steven I.  

Pharmaceuticals, Vol. 8, Iss. 3, 2015-09 ,pp. : 607-636

MDPI

Access to resources Recommend Favorite

Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey

By Baer William H.   Maini Archana   Jacobs Ira  

Pharmaceuticals, Vol. 7, Iss. 5, 2014-05 ,pp. : 530-544

MDPI

Access to resources Recommend Favorite

Dairy Product Consumption and Risk of Non-Hodgkin Lymphoma: A Meta-Analysis

By Wang Jia   Li Xutong   Zhang Dongfeng  

Nutrients, Vol. 8, Iss. 3, 2016-02 ,pp. : 120-120

MDPI

Access to resources Recommend Favorite

Polymorphisms in DNA Repair Genes and MDR1 and the Risk for Non-Hodgkin Lymphoma

By Kim Hee Nam   Kim Nan Young   Yu Li   Kim Yeo-Kyeoung   Lee Il-Kwon   Yang Deok-Hwan   Lee Je-Jung   Shin Min-Ho   Park Kyeong-Soo   Choi Jin-Su   Kim Hyeoung-Joon  

International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-04 ,pp. : 6703-6716

MDPI

Access to resources Recommend Favorite

Non-Coding RNAs in Hodgkin Lymphoma

By Cordeiro Anna   Monzó Mariano   Navarro Alfons  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 1154-1154

MDPI

Access to resources Recommend Favorite